Evaluating whether LIT supplementation slows cognitive decline in Alzheimer’s patients

Teona Gherasim

Fujita Health University Nov 19 2025 Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring the urgent need for novel neuroprotective strategies. Lithium (LIT), a well-known mood stabilizer for the treatment of bipolar disorder, shows neuroprotective effects,

din zilele anterioare